These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 28128116)

  • 1. Tachyphylaxis to Topical Therapy with Clobetasol Propionate.
    Singh PK
    Indian J Dermatol Venereol Leprol; 1989; 55(6):362-363. PubMed ID: 28128116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
    Singh S; Gupta A; Pandey SS; Singh G
    Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of reservoir effect of clobetasol propionate cream in an experimental animal model using histamine-induced wheal suppression test.
    Abidi A; Ahmad F; Singh SK; Kumar A
    Indian J Dermatol; 2010 Oct; 55(4):329-33. PubMed ID: 21430883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression.
    Singh G; Singh PK
    Int J Dermatol; 1986 Jun; 25(5):324-6. PubMed ID: 3721670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
    Singh SK; Nasir F
    Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of clobetasol propionate with varying dilutions of emollient determined by histamine wheal suppression test.
    Barathi M; Rai R; Srinivas CR
    Indian J Dermatol; 2011; 56(5):527-8. PubMed ID: 22121270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half an hour versus three hour contact of topical steroid (clobetasol propionate).
    Rai R; Uppal M; Sharma NK; Srinivas CR; Mathew A
    Indian J Dermatol Venereol Leprol; 2004; 70(4):214-6. PubMed ID: 17642617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of topical corticosteroid application frequency on histamine-induced wheals.
    Narasimha SK; Srinivas CR; Mathew AC
    Int J Dermatol; 2005 May; 44(5):425-7. PubMed ID: 15869544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Potency of Topical Corticosteroid Preparations.
    Singh PK; Singh G
    Indian J Dermatol Venereol Leprol; 1985; 51(6):309-312. PubMed ID: 28164900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of topical clobetasol propionate by visual score, electrical impedance and laser Doppler flowmetry.
    Emtestam L; Kuzmina N; Talme T
    Skin Res Technol; 2007 Feb; 13(1):73-8. PubMed ID: 17250535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects.
    Au WL; Skinner MF; Benfeldt E; Verbeeck RK; Kanfer I
    Skin Pharmacol Physiol; 2012; 25(1):17-24. PubMed ID: 21860254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topically applied clobetasol-17-propionate on histamine release in human skin.
    Ståhle M; Hägermark O
    Acta Derm Venereol; 1984; 64(3):239-42. PubMed ID: 6204486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating umbilical granuloma with topical clobetasol propionate cream at home is as effective as treating it with topical silver nitrate in the clinic.
    Brødsgaard A; Nielsen T; Mølgaard U; Pryds O; Pedersen P
    Acta Paediatr; 2015 Feb; 104(2):174-7. PubMed ID: 25297721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound evaluation of clobetasol propionate 0.05% foam application in psoriatic and healthy skin: a pilot study.
    Lacarrubba F; Nardone B; Musumeci ML; Micali G
    Dermatol Ther; 2009 Nov; 22 Suppl 1():S19-21. PubMed ID: 19891687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
    Andres P; Poncet M; Farzaneh S; Soto P
    J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial.
    Menter A
    Cutis; 2007 Nov; 80(5 Suppl):12-9. PubMed ID: 18154219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.